Financial Statements and Approvals - Agfa-Gevaert's Annual General Meeting approved the 2024 financial statements, allocation of the result, remuneration report, remuneration policy, and discharge of directors and statutory auditor [1] - Shareholders made available all share premiums to allow the Board of Directors to offset incurred losses [2] Auditor Appointment - PwC Bedrijfsrevisoren BV/PwC Réviseurs d'Entreprises SRL was appointed as the statutory auditor responsible for the assurance of the stand-alone and consolidated sustainability information of the company [2] Company Overview - The Agfa-Gevaert Group is a prominent player in imaging technology and IT solutions with over 150 years of experience, operating in three divisions: Radiology Solutions, HealthCare IT, and Digital Print & Chemicals [3] - In 2024, the Group achieved a turnover of 1,138 million euro [3]

                                        March 11, 2025 – 5.40 PM CET Regulated information Extraordinary General Meeting of Agfa-Gevaert NV Mortsel, Belgium – March 11, 2025 – 5.40 p.m. CET On Tuesday, March 11, Agfa held an Extraordinary General Meeting at its head office in Mortsel, Belgium. At the meeting, the shareholders approved the reduction of the capital of the Company to the amount of 26,000,000.00 euro by offsetting losses incurred in the amount of 160,794,611.00 euro. Also approved were clarifi ...